Archive for the ‘Treatment’ Category

Ask A Lyme Doctor: Q & A With Dr. Tania Dempsey

https://www.globallymealliance.org/blog/dr.-tanya-dempsey-questions?

Dr. Tania Dempsey is an expert in chronic disease, autoimmune disorders and mast cell activation syndrome. In this blog, she is answering Lyme related questions that GLA followers submitted via social media.
Are you seeing cases where Covid has re-activated Lyme or ignited new auto-immune diseases or mast cell activation syndrome? -Kimberly H.

We are just at the beginning of really understanding how COVID interacts with our immune system. Since there are few studies that have been published that give us complete clarity on this, much of what I discuss is based on my experience with my patients. What seems clear to me is there is often some sort of vulnerability or predisposition in the patient, like an autoimmune potential, underlying dysfunctional mast cells, or a history of chronic infections, that leads to the complications that we are seeing post-COVID. I have not yet seen post-COVID patients who did not have some hint of an underlying issue prior to COVID. I have patients who have a history of Lyme disease that is well controlled for a number of years but after COVID they see a recurrence in the symptoms that pre-dated their Lyme treatment. Some of these patients have new symptoms and I postulate that it could be related to their underlying old infection that reactivated in a new location in their body or the new symptoms represent a worsening of their immune dysfunction. COVID seems to both stimulate and suppress the immune system, depending on the timing of the infection and on the susceptibility of the person. If the patient has a history of Lyme disease that is chronic/persistent, we know that their immune system continues to be affected. The vast majority of Chronic Lyme patients (in my practice) have underlying dysfunction of their mast cells, even if they have not been formally diagnosed with mast cell activation syndrome. Many of them had a predisposition before being infected with Lyme, which was worsened by the infection. Since infections of various kinds are known to trigger mast cells, chronic infection can cause chronic mast cell activation that then can be triggered further by a new infection, such as COVID. The relationship between mast cells and other immune cells has been well described and MCAS can be a driver of the development of autoimmunity.

How should I deal with post Lyme flare ups? -Debra C.

There are three main scenarios that I see as contributors for “post-Lyme flares”.

  1. Mast Cell Activation Syndrome (MCAS) is a leading culprit for increased symptoms after Lyme treatment. Whether there is underlying primary MCAS or secondary MCAS triggered by the infection, mast cells often continue to be dysfunctional even after the infection is cleared. Mast Cell Targeted Therapy can be very helpful in stabilizing mast cells, minimizing mediator release and thereby minimizing inflammation.
  2. Another important possibility to consider when patients have flares of symptoms after treatment for Lyme, is the presence of “co-infections.” Treating Lyme can make room for other infections to reactivate, like viruses (EBV, HHV-6, etc), Babesia, Bartonella, and many other microbes. It is important to look for other infections while treating Lyme, so as to not miss the need for other types of treatment.
  3. Persister Lyme is a major cause of  “Post-Lyme flares.” The bacteria that causes Lyme, Borrelia Burgdorferi, can exist in a slow-growing, persister form that is resistant to antibiotics and other anti-microbial treatment. Even aggressive treatment for Lyme disease can leave behind these persister organisms that can continue to wreak havoc on the body.
What are the best current treatment for “stubborn” Bartonella? -Deb T.

Bartonella is probably one of the most difficult chronic infections that I’ve had to treat in my practice. It is necessary to use a multi-pronged approach in treatment of Bartonella. Some patients have other co-infections, which complicates the treatment as well. While I don’t think there is a “best” treatment for Bartonella yet, in my practice what I have found helpful is a combination of modalities, which could include SOT therapy (Supportive Oligonucleotide Technique), Ozone therapy, Herbal protocols and/or Antibiotics, and other therapies.

GLA is currently fundraising for The Bartonella Discovery Program, a research project bringing together some of the top researchers world-wide who are experts on Bartonellosis. These researchers will learn more about the bacteria and which treatments are most likely to cure patients.

How do you heal the nervous system after neurological Lyme and Bartonella ravage it? -Katie M.

Healing the nervous system after Lyme, Bartonella or other infections is a complicated process.  Reducing inflammation, not just by treating the infections, but also by targeting the immune cells that can continue to cause inflammation, is key. We have a considerable amount of evidence that mast cells in the central nervous system are in constant communication with other immune cells like astrocytes and microglial cells and together can be a major driver of neuroinflammation. There is no cure for neuroinflammation but there are a vast number of drugs and natural treatments that have been studied and some show promise in reducing the neuroinflammatory process. Some strategies include mast cell targeted therapy, treatment with natural compounds such as proresolving mediators (SPMs), PEA (palmitoylethinolamide), resveratrol, turmeric, and others, and various drugs like low-dose naltrexone, minocycline, NSAIDS, and steroids. Treatment needs to be individualized and other confounding medical conditions should be taken into account when choosing a protocol against neuroinflammation.

The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history.
GLA Contributor

Dr. Tania Dempsey

GLA Contributor

*Opinions expressed by contributors are their own. Dr. Tania Dempsey is an expert in chronic disease, autoimmune disorders and mast cell activation syndrome. She received her MD from The Johns Hopkins University School of Medicine and her BS degree from Cornell University. Dr. Dempsey completed her Residency at NYU Medical Center/ Bellevue Hospital. She is Board Certified in Internal Medicine and a Diplomate of the American Board of Integrative and Holistic Medicine. Dr. Dempsey opened the AIM Center for Personalized Medicine, where she currently practices.

Email: info@aimcenterpm.com

For more:

Good News For Pain Patients & Their Physicians From the U.S. Supreme Court

https://www.paintreatmentdirectory.com/posts/good-news-for-pain-patients-and-their-physicians-from-the-u-s-supreme-court

Good News for Pain Patients and Their Physicians from the U.S. Supreme Court

Good News for Pain Patients and Their Physicians from the U.S. Supreme Court

7/4/22

In a rare unanimous decision, the U.S. Supreme Court recently held that a physician who writes opioid prescriptions for their pain patients is not committing a criminal act. This will hopefully put an end to physicians refusing to treat pain patients due to fear of criminal prosecution.

History of Prosecution of Physicians for Opioid Prescribing

For over two decades the U.S. Drug Enforcement Agency (DEA) has been selectively raiding the offices of physicians who were writing prescriptions for high doses of opioids, seizing their records and assets, and charging them as drug dealers under the Controlled Substances Act (CSA). While a few of these doctors may have been operating pill mills, writing prescriptions or directly selling opioids to recreational users or drug addicts, most were engaging in the legitimate practice of medicine. They were prescribing opioids to help their pain patients manage their pain.

These targeted physicians lost their licenses, life savings and livelihoods, and many ended up in prison, some for terms of 20 years or longer. This has had a chilling effect on other physicians, many of whom abruptly discontinued or abruptly tapered their opioid-dependent patients off their opioids or abandoned them altogether. The practice became much more common after the CDC published opioid prescribing guidelines in 2016 with recommended dosage and duration limits.

This abrupt reduction in opioid prescriptions caused great suffering for pain patients, throwing them into horrific withdrawal and left them with no way to manage their pain. These patients were shunned by other doctors who were afraid to take them on. Some patients committed suicide; others turned to more dangerous street drugs. The rest suffered more and had reduced functionality and quality of life.

The Supreme Court Decision on Prosecution of Opioid-Prescribing Physicians

A unanimous decision of the U.S. Supreme Court issued on June 27, 2022, in the combined cases of Ruan v United States and Kahn v United States may finally put an end to these egregious practices. The Supreme Court held:

“the Government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner.

Previously the standard of proof being used was a preponderance of evidence, a lower bar that the justices found unsuitable given the harsh sentences that were possible under the CSA. Also, previously the defense that doctors were acting in good faith to help their pain patients as authorized by their licenses was not accepted by the lower courts.

This is not a “get out of jail free card” for Ruan or Kahn. Their cases are being referred back to the lower courts for review or retrial under the new standards. The same holds true for any other physicians currently serving time for similar charges. It remains to be seen at what point other physicians will feel reassured and feel safe to prescribe opioids again.

One Prosecuted Physician Who Has Been Documenting the Abuses

I recently spoke with Linda Cheek, a retired family practice physician who operates a website, www.doctorsofcourage.org, that tracks cases of physicians charged with opioid drug crimes. Her website currently lists over 1800 physicians who’ve been targeted and the outcomes of their cases. Dr. Cheek was herself charged under the CSA and spent 26 months in prison as a result.

At the time Dr. Cheek was arrested, she was in solo practice as a family practice physician in Virginia. She practiced integrative medicine, combining alternative treatments, including homeopathy and prolotherapy, to treat the root causes of her patients’ pain. She was prescribing opioids as needed until her patients’ pain levels decreased and she could safely taper them off their medication. (As an aside, I first met Dr. Cheek at an integrative pain management conference.)

Dr. Cheek reported that one day 20 law enforcement agents unexpectedly raided her office on the pretext of Medicare/Medicaid fraud and later charged her with drug crimes under the Controlled Substances Act. This is a common tactic, reports Cheek, as almost anyone can be found on a technicality to have committed Medicare/Medicaid fraud. Although Dr. Cheek has completed her prison sentence, her license to practice medicine is still revoked.

According to Dr. Cheek, doctors, particularly minority doctors, who practice alone, have been the primary targets of these arrests. This is because these doctors do not have large institutions to back them up as physicians do who practice in hospital or other large healthcare settings.

What Happens Next

It remains to be seen what will happen to Ruan and Kahn when their cases go back to the lower courts and what will happen with other doctors who have been prosecuted under the CSA. It will most likely take a while for physicians who treat pain to be reassured that they are no longer at legal risk for using tools they are authorized to use to help their patients, but this Supreme Court decision is at least one step in the right direction.

The Bottom Line

As long-time readers of my blog know, I am not a fan of opioids for pain relief. I believe there are safer and more effective options. However, most physicians are not educated in alternative treatments for pain and those that are find that most of their patients cannot afford to access alternatives due to lack of insurance coverage. Criminalization of opioid prescribing for pain has resulted in significant harm to patients and their physicians and the sooner this stops the better. Patients and their doctors need education about and affordable access to alternative care and the ability to voluntarily taper if and when other methods relieve or eliminate their pain.

Find an Alternative Pain Treatment Provider

Find Natural Pain Relief Products

The author, Cindy Perlin, is a Licensed Clinical Social Worker, certified biofeedback practitioner and chronic pain survivor. She is the founder and CEO and the author of The Truth About Chronic Pain Treatments: The Best and Worst Strategies for Becoming Pain Free. She’s located in the Albany, NY area, where she has been helping people improve their health and emotional well-being for over 28 years. See her provider profile HERE. She is available for both in-office and virtual consultations. 

Relapsing Babesia Treated Successfully With Tafenoquine & A Real Reason For Antibiotic Resistance: Livestock Farming

The following case report is an update from an earlier version.  The reason I include it is found in the comment section.

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciac473/6605069

Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine  

Clinical Infectious Diseases, ciac473, https://doi.org/10.1093/cid/ciac473
Published:  10 June 2022

Abstract

We describe a case of relapsing babesiosis in an immunocompromised patient. A point mutation in the Babesia microti 23S rRNA gene predicted resistance to azithromycin and clindamycin whereas an amino acid change in the parasite cytochrome b predicted resistance to atovaquone. Following initiation of tafenoquine, symptoms and parasitemia resolved.

___________________

**Comment**

A wonderful example of how mutations can affect treatment outcome and the importance that a singular drug can make in a person’s life. This person is truly lucky to have this information to help guide their treatment.  Most patients simply have to struggle forward, shooting in the dark to find answers.

The topic of mutations is rarely is discussed or researched and is clearly an area begging for more work to be done.  How many more patients out there have this problem?

We need treatments, not a supposed magic-cure all injection.

For more:

___________________

Another topic that is rarely discussed or researched is the very real problem with wide-spread use of antibiotics in healthy animals in live-stock farming.

https://www.theepochtimes.com/study-sounds-alarm-over-new-bacteria-increasingly-spreading-among-humans

Study Sounds Alarm Over New Bacteria Increasingly Spreading Among Humans

By Jack Phillips
June 30, 2022

A strain of antibiotic-resistant bacteria discovered in pigs is spreading to people and causing infections, according to a new study released this week.

A strain of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) is suspected to have merged among European pigs and other livestock in the past several decades because of frequent antibiotic use in farming.

Historically high levels of antibiotic use” may have led to the cause of this “highly antibiotic-resistant strain of MRSA on pig farms,” said Dr. Gemma Murrayn, who worked on the study released by the University of Cambridge, in a news release. 

“We found that the antibiotic resistance in this livestock-associated MRSA is extremely stable—it has persisted over several decades, and also as the bacteria has spread across different livestock species,” Murrayn added in the news release.

(See link for article)

A New Look At Chronic Lyme

https://experiencelife.lifetime.life/article/a-new-look-at-chronic-lyme/

image compilation lyme disease
(See link for article)
SUMMARY:
  • Weintrub highlights Jennifer Crystal’s story which mimics many other patients
  • Unfortunately, the article regurgitates the notion that only up to 20% experience chronic symptoms when the number is more like 60%
  • Weintraub explains that historically LLMD’s used high doses of antibiotics/antimalarials in harsh regimens lasting months or years but due to grueling side effects have adopted a multi-pronged approach that combines the judicious use of drugs which includes natural therapies
  • The article also erroneously blames rising temperatures for tick expansion when independent research has shown this to be false
  • The reason infections are reported in every state but Hawaii and Oklahoma has to do with migrating birds, reptiles, and mammals – including humans.
  • Weintraub explains the difference between the “two types” of Lyme disease: the acute, straight-forward cases, and those who remain sick after standard treatment, who are typically diagnosed late, and who have more than one infection – which research confirms who are as impaired as those with congestive heart failure and sicker than type 2 diabetics, and who have a striking degree of neuro-inflammation
  • Unfortunately, this second group which suffers greatly with chronic infections is still gas-lit by physicians who would rather label them with chronic fatigue or fibromyalgia and give them “scattershot” treatment
  • The article then goes into the big problem with faulty Lyme testing which can not register antibodies for 6 weeks, miss a significant subset of people who will always remain seronegative, that can not register certain strains of borrelia, or pick up the organism which lies dormant within tissues.
  • Despite a CDC disclaimer, many doctors still rely on the faulty CDC surveillance case definition which requires a positive test or the EM rash, when many will never test positive and many never get a rash.
  • I was thankful for Dr. Maloney who states an early course of antibiotics does NOT eliminate the risk for chronic Lyme
  • The article then delves into the fact many patients are infected with way more than just Lyme
  • Researchers that previously doubted that Bartonella could be spread by ticks are changing their position as there is now strong circumstantial evidence
  • The article points out that research has identified “persister cells” which are antibiotic tolerate and generally unresponsive to drugs as well as biofilms which work to protect infectious organisms, also making it hard to eliminate them
  • Stanford researchers have exposed persister forms (in vitro) to more than 4,000 drugs to observe effectiveness which has resulted in the use of disulfiram/Antabuse, an old drug for use for alcoholism but is potent against Lyme disease (but can cause severe side-effects in some)
  • Dr. Zhang has tested lyme-containing biofilms (in vitro) using antibiotics and herbs and has found that Japanese knotweed, black walnut, sweet wormwood, and Ghanaian quinine are all effective against Lyme disease.
  • Dr. Horowitz has found that a 2-month course of dapsone combined with biofilm buster rifampin has helped almost half of his chronically ill patients return to health. One patient accidentally took quadruple the dose for 4 days which put her into full remission – another example of how dosage matters.  A few other patients used this approach with similar success leading Horowitz away from long-term antibiotics to hitting hard for several days 3-4 times a year
  • Dr. Kinderlehrer reports that a formerly straightforward infection has morphed into body-wide instability: extreme sensitivities to foods, mold, chemicals, activation of mast cells, and dangerous allergic reactions, which can trigger brain fog, mood problems, pain syndromes, and profound fatigue.
  • A suppressed immune system can reactivate other infections like EBV
  • Integrative doctor Erica Lehman’s experience has taught her to recognize the different between those with neurologic disease versus illness that hits the gut, endodrine system, joint tissues, etc.
  • Many of the doctors who specialize in chronic Lyme do so because they have gone through it themselves

I highly, highly recommend Weintraub’s 2008 book “Cure Unknown: Inside the Lyme Epidemic.”  Although it was written 14 years ago, it remains one of the most thorough, accurate accounts of the Lyme debacle and clearly demonstrates that little has changed.

She also wrote about Dr. Masters the Rebel for Lyme Patients Who Took on the CDC Single-handedly  and broke it down into four parts in Psychology Today and which I summarize in the link. This history must not be lost. 

We must remember the fraud and corruption behind & in the world of Lyme/MSIDS.

Fauci Gets COVID Yet Again After Taking Paxlovid, Proving the Drug that Cost Taxpayers $10.6 Billion is Worthless

https://childrenshealthdefense.org/defender/fauci-covid-rebound-pfizer-paxlovid-taxpayers

Fauci Gets COVID Again After Taking Pfizer’s Treatment — the Drug That Cost Taxpayers $10.5 Billion

Dr. Anthony Fauci said Tuesday he is experiencing a rebound of COVID-19 symptoms after taking Paxlovid, Pfizer’s COVID-19 antiviral pill. Taxpayers are on the hook for $10.5 billion worth of the experimental treatment, under a deal the White House cut with Pfizer.

Excerpts:
Fauci tested positive for COVID-19 on June 15, despite being quadruple-vaccinated, initially experiencing “mild symptoms,” according to the NIAID.
Summary:
  • Due to his age he was put on a five day treatment of the expensive and rushed to market drug Paxlovid, which experts admit has a track record of causing a rebound of COVID, yet the CDC illogically continues to recommend it. Despite all common sense, logic, and science, the CDC will never in 1,000 years promote HCQ or ivermectin, vitamin C & D, and other effective, safe, cheap medications/supplements, just like they will never promote extended antibiotics for Lyme/MSIDS
  • Despite testing negative (as if that means anything) for three days in a row, Fauci reverted back to positive on the fourth day after treatment
  • His rebound felt worse than the first time he had COVID
  • Please know that while Biden’s “Test to Treat” initiative which supposedly allows Americans who test positive for COVID at a pharmacy to obtain “free” antiviral pills on the spot, these “free” pills have cost the U.S. taxpayer $10.6 BILLION.  
  • Dr. David Gortler, pharmacologist, pharmacist, FDA and healthcare policy oversight fellow and FDA reform advocate at the Ethics and Public Policy Center, questions why the government continues to invest in Paxlovid given it’s lack of performance.  He then rips the Pfizer study to shreds:
    • While Pfizer claims the drug reduces hospitalization and death by nearly 90% in people with mild to moderate infections, nearly everyone who gets the existing COVID mutation will have mild or moderate disease. 
    • Pfizer limited its study to people who were unvaccinated and who faced the greatest risk from the virus
    • An updated more recent analysis from 1,153 patients (out of a possible 2,246) showed a non-significant 51% relative risk reduction.
    • Gortler wants to know why Biden gambled every tax dollar on ONE single drug from ONE single drugmaker, Pfizer, …when they could have spent almost nothing and promoted the established safety and efficacy of hydroxychloroquine and ivermectin with an established, superior outcome.”

Please see this powerful FLCCC graphic comparing Paxlovid vs ivermectin.

Pfizer stands to make $54 billion in sales in 2022 from its vaccine and Paxlovid, The Defender reported in March.